Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
In summary, available data demonstrate that IL-1 and TNF are the causative agents underlying the bone loss induced by estrogen deficiency. Indeed, these factors are produced in bone and the bone marrow, released in larger amounts from cells of estrogen-deficient subjects, and indispensable for reproducing the effects of estrogen deficiency in bone. These observations support the hypothesis that the bone sparing effect of estrogen is due to the ability of the hormone to block osteoclastogenesis, the activation of mature osteoclasts and, as recently demonstrated, the rate of apoptotic osteoclast death. Although IL-1 and TNF play a prominent causal role in these events, the bone-sparing effect of estrogen is mediated by numerous cytokines which, by simultaneously stimulating multiple target cells, induce effects that are not accounted for by any one single factor (Fig. 2). The ability of estrogen to regulate some, but not all, the cytokines involved in this process is not inconsistent with this hypothesis because cytokines have potent synergistic effects. Thus, a considerable increase in bone resorption may result from a relatively small increase in the concentration of only a few of the bone-resorbing factors present in the bone microenvironment. This concept is best illustrated by the study of Miyaura et al. demonstrating that the concentrations of either IL-1, IL-6, IL-6 receptor, or prostaglandins detected in the bone marrow of OVX mice are insufficient to account for the increased bone resorption caused by estrogen withdrawal. In contrast, the increase in bone resorption induced by OVX can be explained by the cumulative effects of these cytokines. Thus, a better understanding of the cooperative effects of cytokines and a recognition that the contribution of individual cytokines to postmenopausal bone loss varies with the passage of time after menopause are necessary to fully understand the mechanism of action of estrogen in bone. Although the relevance of individual bone-targeting cytokines in species specific, the development of transgenic mice with activatable or deactivatable promoters is likely to result in a further clarification of the integrated action of estrogen-regulated cytokines in human bone cells and lay the foundations for the use of cytokine inhibitors in the treatment of postmenopausal osteoporosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Estrogen acts via suppression of bone resorption [43–45]”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [44]
In the citing paper
“In addition, estrogen inhibits osteoclast formation by reducing the levels of other osteoclastogenic cytokines such as IL-1, IL-6, IL-11, TNF-α, TNF-β, and M-CSF [160, 161].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [160]
Citations
Cites
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004 · cited 2×
“(22) These mice, which are cured by the administration of M-CSF,(3s) have an extra thymidine inserted within the coding region of the M-CSF gene, a mutation that generates a stop codon within the coding sequence,(3h) thereby resulting in the production of a defective M-CSF.(22) The formation of osteoclasts in bone mar…”
BackgroundSoluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
TURNER, R. T., RIGGS, B. L., & SPELSBERG, T. C. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-275 · Cited by 754
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Research works printed but not linked: 11
- Srivastava, 1995, Estrogen down-regulates the expression of M-CSF mRNA in bone marrow stromal cells by stimulating the production of the transcription factor EGR-1, J Bone Miner Res, 10, S18
- Matayoshi, 1995, Generation of human osteoclasts from peripheral blood cd 34+ cells, J Bone Miner Res, 10
- Pacifici, 1990, TNFα and GM-CSF secretion from human blood monocytes: Effect of menopause and estrogen replacement, J Bone Miner Res, 5, 145
- Kimble, 1996, Estrogen inhibits IL-1 and TNF gene expression in transfected murine macrophagic cells, J Bone Miner Res, 11
- Kaneki, 1991, The effect of menopause on IL-1 and IL-6 release from peripheral blood monocytes, J Bone Miner Res, 6, 76
- Thompson, 1991, IL-lra: Properties and uses of an interleukin-1 receptor antagonist, Agents Actions, 41
- Girasole, 1995, Increased serum soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement, and reversed by alendronate administration, J Bone Miner Res, 10, A86
- McKane, 1993, Effect of age and menopause on serum interleukin-1β and intereleukin-6- levels in women, J Bone Miner Res, 8, 162A
- Kimble, 1994, Long-term treatment with IL-1 receptor antagonist (IL-lra) blocks bone loss in ovariectomized rats, J Bone Miner Res, 9, B380
- Kimble, 1995, Inhibition of IL-6 activity is genetically normal mice does not prevent ovariectomy-induced bone loss, J Bone Miner Res, 10, s160
- Ammann, 1995, Transgenic mice expressing high levels of soluble tumor necrosis factor receptor-1 fusion protein are protected from bone loss caused by estrogen deficiency, J Bone Miner Res, 10
Cited by
Items 501–600 of 743
Damani, J. J., Oh, E. S., Souza, M. J. D., Strock, N. C. A., Williams, N. I., Nakatsu, C. H., Lee, H., Weaver, C. M., & Rogers, C. J. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.11.014 · Cited by 11
Li, C., Zang, X., Liu, H., Yin, S., Cheng, X., Zhang, W., Meng, X., Chen, L., Lu, S., & Wu, J. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00470 · Cited by 9
Predicting Response to Radiotherapy in Cancer-Induced Bone Pain: Cytokines as a Potential Biomarker?
MacLeod, K., Laird, B. J. A., Carragher, N. O., Hoskin, P., Fallon, M., & Sande, T. A. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.03.010 · Cited by 9
Yu, H., Zhou, W. Z., Zhong, Z., Qiu, R., Chen, G., & Zhang, P. (2022) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-022-03110-8 · Cited by 9
“It is a fact that inflammatory reaction can regulate bone formation and resorption [7].”
BackgroundRetractedAnalyzing Sex-Specific Dimorphism in Human Skeletal Stem Cells
Niemann, T., Joneleit, J., Storm, J., Nacke, T., Wähnert, D., Kaltschmidt, C., Vordemvenne, T., & Kaltschmidt, B. (2023) · Cells · doi:10.3390/cells12232683 · Cited by 9
Loss of Cbl–PI3K interaction in mice prevents significant bone loss following ovariectomy
Adapala, N. S., Holland, D., Scanlon, V. M., Barbe, M. F., Langdon, W. Y., Tsygankov, A. Y., Lorenzo, J. A., & Sanjay, A. (2014) · Bone · doi:10.1016/j.bone.2014.06.013 · Cited by 9
“Levels of CTX, P1NP, IL-1β, IL-6, TNF-α and osteopontin in serum was determined using commercial kits.”
BackgroundInfluentialJin, X., Zhou, B., & Zhang, D. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0204 · Cited by 10
“Previous studies reported that estrogen deficiency in postmenopausal women could lead to exceed the bone resorption by osteoclasts over bone formation by osteoblasts and ultimately cause osteoporosis (Pacifici, 1996).”
Wang, W., Huang, C., Wang, Z.-P., Xu, S., Qian, T.-Y., Chen, Y., & Wu, W. (2019) · Journal of Medical Biochemistry · doi:10.2478/jomb-2018-0042 · Cited by 9
Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats
Kim, J., Kim, H., Kim, S. H., Imm, J.-Y., & Whang, K. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3441 · Cited by 9
Koshihara, M., Masuyama, R., Uehara, M., & Suzuki, K. (2005) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.69.1970 · Cited by 9
An overview of osteoporosis for the practising prosthodontist
Singh, S. V., & Tripathi, A. (2010) · Gerodontology · doi:10.1111/j.1741-2358.2009.00324.x · Cited by 11
Mechanisms of Estrogen Action in Bone
Pacifici, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00059-8 · Cited by 10
Self-citationOnodera, S., Oshima, S., Nishihira, J., Yasuda, K., Tohyama, H., Irie, K., & Koyama, Y. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.066 · Cited by 9
Correction: Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
Visser, K., Mortimer, M., & Louw, A. (2013) · PLoS ONE · doi:10.1371/annotation/3306cc63-2aab-42b1-98c1-7507705fff98 · Cited by 9
The Treatment of Inflammation, Pain, and Fever Using Medicinal Plants
Akkol, E. K., Das, S., Sarker, S. D., & Nahar, L. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/476985 · Cited by 11
“However, exploring the methods applied in the published reports on evaluation of antinociceptive, anti-inflammatory, and/or antipyretic activity of mangrove plants [4–34], the following assumptions can be made about the possible mechanisms of actions.”
BackgroundMethodInfluentialWhitman, P. W., Alexander, C. J., Kaluta, L., Burt, L. A., & Gabel, L. (2025) · Bone · doi:10.1016/j.bone.2025.117650 · Cited by 9
The development, incidence and treatment trends of trochanteric fractures in Germany: a cohort study
Rau, Y., Amtsfeld, J., Reimers, N., Matrisch, L., Frese, J., & Schulz, A. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03981-5 · Cited by 11
Pérez‐Castrillón, J. L., Vega, G., Abad, L., Sanz-Cantalapiedra, A., Sagrado, M. G., de Luis, D. A., & Dueñas‐Laita, A. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000170886 · Cited by 8
“Inflammatory cytokines play an important role in the imbalance between bone formation and resorption that leads to the reduced bone mass seen in osteoporosis [”
BackgroundLi, Y., Ou, Y., Zhu, Y., Zhao, Z., He, B., Xu, S., & Yu, H. (2020) · Journal of Orthopaedic Science · doi:10.1016/j.jos.2020.05.013 · Cited by 8
Goldberg, S., Glogauer, J. E., Grynpas, M. D., & Glogauer, M. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-9994-4 · Cited by 8
“As a consequence, a high turnover state develops which leads to bone loss and perforation of trabecular plates [10, 11].”
BackgroundRole of Sex Hormones in Human Body
Aubead, N. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95778 · Cited by 12
Recognition and Treatment of Postmenopausal Osteoporosis
Hannafon, F., & Cadogan, M. P. (2014) · Journal of Gerontological Nursing · doi:10.3928/00989134-20140204-01 · Cited by 10
Saltzman, W., Abbott, D. H., Binkley, N., & Colman, R. J. (2018) · American Journal of Primatology · doi:10.1002/ajp.22905 · Cited by 8
“marmosets could involve cytokines or leptin, both of which are regulated by estrogen and contribute to estrogen-depletion bone loss in humans and rodents (Haberland, Schilling, Rueger, & Amling, 2001; Pacifici, 1996; Shimizu et al., 1997).”
Sex steroids concentrations in relation to bone mineral density in men with coronary atherosclerosis
Dunajska, K., Milewicz, A., Jóźków, P., Jędrzejuk, D., Kuliczkowski, W., & Lwow, F. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.01.007 · Cited by 8
Uemura, H., Yasui, T., Umino, Y., Niki, H., Takikawa, M., Saito, S., Furumoto, H., & Irahara, M. (2003) · Bone · doi:10.1016/j.bone.2003.08.001 · Cited by 7
“Previous studies have identified several candidate mediators of the increased bone resorption [14,15].”
BackgroundHamedi, F., Alizadeh, M., & Kheirouri, S. (2025) · Bone · doi:10.1016/j.bone.2025.117622 · Cited by 7
Cellular and humoral immune responses after short-term oral hormone therapy in postmenopausal women
de Medeiros, S. F., & Maitelli, A. L. (2011) · Climacteric · doi:10.3109/13697137.2011.570387 · Cited by 7
Myśliwiec, J., Adamczyk, M., Nikołajuk, A., & Górska, M. (2011) · PubMed · Cited by 8
Abl interactor 1: A novel biomarker for osteoporosis in Chinese elderly men
Zhou, X., Li, C., He, P., Wu, L., Lu, X., Lei, S., & Deng, F. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103440 · Cited by 8
Fan, Y., Tang, R., Prior, J. C., & Chen, R. (2020) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2020.11.004 · Cited by 8
Mirfakhraee, S., Sakhaee, K., Zerwekh, J. E., ADAMS-HUET, B. A., & Gruntmanis, U. (2012) · Archives of Osteoporosis · doi:10.1007/s11657-012-0110-3 · Cited by 7
“Additionally, estrogen deficiency causes increased cytokine production (especially TNF-α and IL-1β) [35], which increases RANKL expression and stimulates osteoclast development [36].”
BackgroundRava, A., Pihlak, A., Kums, T., Purge, P., Pääsuke, M., & Jürimäe, J. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01222-6 · Cited by 7
Singh, V., Singh, A., Quadri, S. S. Y. H., Mullapudi, S. V., Mahesh, J., Rao, B., Nemani, H., & Kumar, B. D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111976 · Cited by 8
Sex Difference in the Socioeconomic Burden of Osteoporosis among South Koreans
Lee, E.-W., & Nam, J. Y. (2021) · Healthcare · doi:10.3390/healthcare9101304 · Cited by 7
“This higher prevalence in women is primarily because 80% of primary osteoporosis is caused by estrogen deficiency [4,28].”
BackgroundCan the FRAX tool be a useful aid for clinicians in referring women for periodontal care?
Alli, F., Bhandal, G. K., Thacker, H. L., & Palomo, L. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000272 · Cited by 7
He, Z., & Ren, D. (2018) · InTech eBooks · doi:10.5772/intechopen.74157 · Cited by 8
“Estrogen has an inhibitory effect on bone resorption by directly inhibiting osteoclast activity as well as decreasing auto and paracrine production of cytokines such as interleukin (IL) 1 and IL-6 and tumor necrosis factor, TNF [80].”
BackgroundNanes, M. S., & Pacifici, R. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_5 · Cited by 8
Self-citationSong, E. K., Yeom, J.-H., Shin, H. T., Kim, S. H., Shin, W. G., & Oh, J. M. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00753.x · Cited by 7
“Such an effect is more likely to be observed in sites rich in cancellous bone, such as the lumbar spine, characterized by higher turnover rates than the cortical bone (21).”
BackgroundLee, N., Fowler, E. V., Mason, S., Lincoln, D. J., Taaffe, D. R., & Radford‐Smith, G. L. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04679.x · Cited by 8
Han, K. O., Choi, J. T., Moon, I. G., Jeong, M. S., Yim, C. H., Chung, H. Y., Jang, H. C., Yoon, H. K., & Han, I. K. (2002) · Bone · doi:10.1016/s8756-3282(02)00873-6 · Cited by 10
Løbo, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00014-0 · Cited by 8
Daswani, B., Gavali, S., Desai, M. P., Patil, A. D., & Khatkhatay, M. I. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.182618 · Cited by 6
“However, this was not the case in pre category, probably since low BMD group in precategory comprised women with osteopenia (20/20), whereas, low BMD group in post category comprised women mostly with osteoporosis (17/20).”
PHILLIPS, M., & Joshi, K. (2008) · Elsevier eBooks · doi:10.1533/9781845695170.1.3 · Cited by 9
Yang, S., Gao, F., Li, M., & Gao, Z. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/5277356 · Cited by 6
“*ese features can lead to increases in the possibility of both osteoclastogenesis and osteoclast, thus resulting in reduced weight of bone and elevated likelihood for osteoporosis [2].”
BackgroundRetractedOsteogenic differentiation of placenta-derived multipotent cells in vitro
Cheng, C., Chung, C.-A., Su, L.-C., Chien, C., & Cheng, Y. (2014) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.04.011 · Cited by 6
Role of interleukin-6 on RANKL-RANK/osteoprotegerin system in hypothyroid ovariectomized mice.
Myśliwiec, J., Zbucki, R. L., Nikołajuk, A., Myśliwiec, P., Taranta, A., Kamiński, K. A., Bondyra, Z., Dadan, J., Górska, M., & Winnicka, M. M. (2011) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-010-0064-5 · Cited by 6
Xing, L., He, G.-P., Chen, Y., & Su, Y. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0844-y · Cited by 6
The effects of combined training on bone metabolic markers in postmenopausal women
Pereira, A. B., Costa, A. M., Palmeira‐de‐Oliveira, A., Soares, J., Monteiro, M., & Williams, J. H. H. (2016) · Science & Sports · doi:10.1016/j.scispo.2016.03.003 · Cited by 7
“During the postmenopausal period, typically 50—60 years of life, muscular strength also declines as bone metabolism changes result in reduced bone density [3,4].”
BackgroundEvaluation of Periodontal Status among Premenopausal and Postmenopausal Women- A Comparative Study
Varghese, T., Madhumala, R., Ravi, R., & Varghese, A. (2016) · Annals of International medical and Dental Research · doi:10.21276/aimdr.2016.2.6.de10 · Cited by 6
Wang, K., Han, L., Wang, N., Wang, Y., & Wang, J. (2018) · Food Science and Biotechnology · doi:10.1007/s10068-018-0379-0 · Cited by 6
Giaze, T. R., Shuid, A. N., So, I. N., Muhammad, N., Fauzi, M. B., Arlamsyah, A. M., & Mohamed, N. (2018) · International Journal of Pharmacology · doi:10.3923/ijp.2018.973.980 · Cited by 6
Saul, S. R., & KASE, N. G. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13952 · Cited by 6
Robertsson, C., Savendahl, L. S., & Cardemil, C. (2021) · Bone Reports · doi:10.1016/j.bonr.2021.101089 · Cited by 6
“As estrogens also inhibit several inflammatory cytokines, the decline in estrogen levels increases the levels of proinflammatory cytokines (Pacifici, 1996; Lerner, 2006).”
BackgroundEffects of Petasites japonicus and Momordica charantia L. Extracts on MC3T3-E1 Osteoblastic Cells
Ji, S.-H., Ahn, D.-H., & Jun, M. (2010) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2010.39.2.203 · Cited by 6
Ramalho, A. C., Lazaretti‐Castro, M., Cohen-Solal, M. E., & de Vernejoul, M. C. (2000) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302000000600005 · Cited by 18
“Suda e cols (31) sugerem que a habilidade da IL-6 de estimular o desenvolvimento de osteoclasto requer a adição de IL-6rs exógeno e que a expressão do receptor de IL-6 pelos osteoblastos é indispensável para induzir formação de osteoclastos em co-culturas de osteoblastos com células esplênicas, porém isso não é confir…”
BackgroundInfluentialRude, R. K. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00043-4 · Cited by 10
Cui, B., Bai, T., Wu, Q., Hu, Y., & Liu, Y. (2024) · International Journal of Implant Dentistry · doi:10.1186/s40729-024-00536-z · Cited by 5
“Additionally, certain cytokines, such as tumor necrosis factor α (TNFα), have been shown to cause osteoblast apoptosis [28, 29].”
BackgroundLiang, E., Beshara, M., Sheng, H., Huang, X.-W., Roh, J. M., Laurent, C. A., Lee, C., Delmerico, J., Tang, L., Lo, J. C.-M., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07423-6 · Cited by 5
Park, C. Y., Park, O.-J., Kwon, Y., Lee, J., Yun, C., & Han, S. H. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10441-x · Cited by 5
“Estrogen deficiency leads to the high production of pro-inflammatory cytokines such as interleukin (IL)−1, IL-6, IL-17, tumor necrosis factor-α, and interferon-γ and eventually results in bone loss [31–34].”
Immediate Implant Placement in the Esthetic Zone: A Multi‐Variate Analysis of Influencing Factors
Jin, Y., Deng, C., Yang, X., Man, Y., & Hu, C. (2025) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.13439 · Cited by 5
Ovarian Aging: The Silent Catalyst of Age-Related Disorders in Female Body
Liu, X., Zhao, Y., Feng, Y., Wang, S., Luo, A., & Zhang, J. (2025) · Aging and Disease · doi:10.14336/ad.2024.1468 · Cited by 14
“…interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor (TNF), macrophage colony-stimulating factor (M-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), with IL-1 and TNF being the most potent activators of bone resorption and inhibitors of bone formation [26, 28].”
Giaze, T. R., Shuid, A. N., Soelaiman, I. N., Muhammad, N., Aladdin, N.-A., & Mohamed, N. (2018) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v17i4.7 · Cited by 5
“Fall in bone level of estrogen, a female sex hormone known to stimulate osteoblast differentiation and suppress osteoclast resorptive activity through a cascade of biochemical events, is believed to play a primary causative role in the development of postmenopausal osteoporosis [4].”
BackgroundLøbo, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00015-9 · Cited by 5
Jeong, H., Bae, E.-K., Hwang, J., Park, E., Lee, J., Jeon, C. H., Koh, E., & Cha, H. (2021) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2021.28.2.76 · Cited by 5
“and TNFα increase bone resorption and are downregulated by estrogen [32].”
BackgroundIkawati, M., Ertanto, Y., Endah, E. S., Pudjiraharti, S., Meiyanto, E., & Jenie, R. I. (2022) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v14i1.1787 · Cited by 8
Kim, H., Kim, Y., Cho, K.-H., Han, B., Kim, S. M., Choi, Y. S., Kim, D., Han, K., Lee, Y.-J., & Kim, C.-M. (2015) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0669-z · Cited by 5
Cell–Cell and Cell–Matrix Interactions in Bone
Bonewald, L. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00313-2 · Cited by 6
Huang, Y., Lin, Y., Wu, Y., Zeng, J., Huang, M., Guo, S., Luo, W., Lin, H., & Lin, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7645 · Cited by 5
“PMOP is a disease that results from dramatic bone loss and increased bone destruction, owing to enhanced osteoclastogenesis without a corresponding increase in osteo-blastic activity (2-4).”
Anderson, L. J., Migula, D., Abay, R., Crabtree, S., Graf, S. A., Matsumoto, A. M., Chauncey, T. R., & Garcia, J. M. (2021) · Andrology · doi:10.1111/andr.13117 · Cited by 5
Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice
Haruyama, N., Yamaza, T., Suzuki, S., Hall, B., Cho, A., Gibson, C. W., & Kulkarni, A. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259966 · Cited by 6
“Pacifici showed that monocytes isolated from post-menopausal women displayed increased secretion of interleukin-1β (IL-1β) and tumor necrosis factor- α (TNF- α), which could be reverted by estrogen replacement therapy [49].”
BackgroundNew perspectives on parathyroid hormone therapy
Lane, N. E., & Morris, S. A. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000166383.73153.cf · Cited by 7
Isolation and Cultivation of Osteoclasts and Osteoclast-Like Cells
Osdoby, P., Anderson, F. L., Maloney, W. J., & Collin‐Osdoby, P. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46886-7_6 · Cited by 5
Treatment Considerations in the Management of Age-Related Osteoporosis
Kaplan, N. M., Palmer, B. F., & Rubin, C. D. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40608-1 · Cited by 6
Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments
Zhao, Y., Wang, Q., Liu, S., Wang, Y., Shu, B., & Zhao, D. (2019) · Journal of Visualized Experiments · doi:10.3791/59171 · Cited by 5
Tähtelä, R. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 6
Methods for studying cell death in bone
Boyce, B. F., Hughes, D. E., & Wright, K. R. (2007) · Springer eBooks · doi:10.1007/978-0-585-38227-2_5 · Cited by 5
Chen, L., Zhao, Y., Qiu, J., & Lin, X. (2024) · Medicine · doi:10.1097/md.0000000000038042 · Cited by 5
“[28,29] 33] Estrogen deficiency is a driver of increased cytokine expression.”
BackgroundDietary phosphorus exacerbates bone loss induced by cadmium in ovariectomized rats
Bakhshalian, N., Johnson, S. A., Hooshmand, S., Feresin, R. G., Elam, M. L., Soung, D. Y., Payton, M. E., & Arjmandi, B. H. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000241 · Cited by 4
“Postmenopausal osteoporosis is the most common cause of bone loss and occurs, in part, because of an abrupt cessation of ovarian hormone production, which leads to increased bone turnover.(3,4) In addition, environmental pollutants, such as heavy metals (eg, cadmium [Cd], lead, and aluminum), have been shown to cause…”
BackgroundEffects of Fermented Soybean Paste Chungkukjang on the Immunoreactivity in Ovariectomized Mice
Park, H., Yoon, L., & Kim, H. (2013) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2013.42.12.1930 · Cited by 4
Important gene–gene interaction of TNF-α and VDR on osteoporosis in community-dwelling elders
Liao, L.-N., Li, C.-I., Wu, F.-Y., Yang, C., Lin, C., Liu, C.-S., Lin, W., Li, T., & Lin, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226973 · Cited by 5
Effect of Hypoestrogenism on Oral Cavity
Wulandari, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106681 · Cited by 4
Roles of the Siglec family in bone and bone homeostasis
Ye, Z., Wang, Y., Xiang, B., Wang, H., Tao, H., Zhang, C., Zhang, S., Sun, D., Luo, F., & Song, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115064 · Cited by 4
The Role of the Immune System in the Development of Osteoporosis
Mödder, U. I., Riggs, B. L., & Khosla, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10009-3 · Cited by 4
Atorvastatin and BMD in Coronary Syndrome. Role of Lys656Asn Polymorphism of Leptin Receptor Gene
Pérez‐Castrillón, J. L., Vega, G., Abad, L., Sanz-Cantalapiedra, A., Sagrado, M. G., de Luis, D. A., & Dueñas‐Laita, A. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-269 · Cited by 4
“Inflammatory cytokines play an important role in the imbalance between bone formation and resorption that leads to the reduced bone mass seen in osteoporosis [3].”
BackgroundLee, J. A., Kim, M. S., Koh, J.-S., Kim, M. S., Kim, D. H., Lim, J. S., Kong, C., Song, W. S., Cho, W. H., Lee, S.-Y., et al. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp131 · Cited by 4
Menopause and Care of the Mature Woman
Lobo, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-06986-1.00014-7 · Cited by 7
Chu, K., Lin, X., Li, S., Ma, L., Huang, Y., Wu, F., Shou, M., Cabarrabang, N. A. G., Lan, Y., & Zhou, J. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03560-2 · Cited by 7
Sears, R. (2020) · JAAPA · doi:10.1097/01.jaa.0000662384.93538.a2 · Cited by 3
Dianingati, R. S., Novarina, A., Hana, A. K., & Muntafiah, L. (2013) · Cited by 3
Nouvelles cibles thérapeutiques dans l’ostéoporose
Roux, S. (2010) · Revue du Rhumatisme · doi:10.1016/j.rhum.2009.10.032 · Cited by 5
Dianingati, R. S., Novarina, A., Hana, A. K., Muntafiah, L., & Lukitaningsih, E. (2017) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev6iss2pp42-48 · Cited by 3
Beavers, K. M., Serra, M. C., Weaver, A. A., & Houston, D. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00035-6 · Cited by 6
IL-1 receptor type I expression in breast cancer
Knüpfer, H., Stanitz, D., Brauckhoff, M., Schmidt, R., Knüpfer, M. M., & Preiß, R. (2001) · The Breast · doi:10.1054/brst.2000.0269 · Cited by 3
Toker, A., Aksoy, H., Börekçi, B., & Özkan, A. D. (2007) · DergiPark (Istanbul University) · Cited by 3
Triutomo, D. H., Miranda, A., Tamba, L. J., & Lukitaningsih, E. (2017) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev7iss3pp104-109 · Cited by 3
“Decreased levels of estrogen (17β-estradiol) accelerates differentiation of osteoclasts so that it becomes one of the main causes of osteoporosis in postmenopausal women (Carr, 2003; Pacifici 2006).”
BackgroundPostmenopausal Osteoporosis: How the Hormonal Changes of Menopause Cause Bone Loss
Pacifici, R. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50043-4 · Cited by 7
Self-citationAttenuation of Osteoporosis by n-3 Lipids and Soy Protein
Fernandes, G. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-740-6_31 · Cited by 3
Calza, L., Tampellini, L., Farneti, B., Borderi, M., Pajno, M. C., Biagetti, C., Manfredi, R., Vescini, F., Caudarella, R., & Chiodo, F. (2007) · Infectious Diseases in Clinical Practice · doi:10.1097/01.idc.0000269907.56982.a5 · Cited by 3
Tezuka, M. (2014) · Journal of Autacoids · doi:10.4172/2161-0479.1000105 · Cited by 2
“Accumulating evidence suggests that estrogen deficiency induces bone resorption by increasing levels of proinflammatory cytokines such as IL-1, IL-6, TNF-α and HIF1α which enhance the formation and activation of osteoclasts [3-7].”
BackgroundLu, M., Zhang, Y., Zhang, Y., Yuan, X., Zhang, T., & Song, J. (2025) · Journal of Oral Microbiology · doi:10.1080/20002297.2025.2554381 · Cited by 2
“Researchers have shown that the lack of estrogen increases the expression of inflammatory cytokines, such as PGE2, TNF α , M-CSF IL-1, and IL-6 [8,9].”
Metadata
- Authors
- Pacifici, R.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Pacifici, Roberto
- ORCID
- Pacifici, Roberto
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-08-01
- Volume
- 11
- Issue
- 8
- Pages
- 1043-1051
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2110993073
- Cited by
- 741
- References
- 90
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 15 · 2023: 20 · 2022: 20 · 2021: 24 · 2020: 20 · 2019: 26 · 2018: 30 · 2017: 15 · 2016: 19 · 2015: 31 · 2014: 29 · 2013: 22 · 2012: 28
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag013534-04)
- National Institute on Aging (AG 13534)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041412, AR41412)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- postmenopausal osteoporosis, estrogen deficiency, cytokines, interleukin-1, TNF-α, bone resorption, osteoclastogenesis, osteoclast apoptosis, bone marrow, cytokine synergy, estrogen withdrawal, cytokine inhibitors
- MeSH terms
- Animals, Bone and Bones, Bone Resorption, Estrogens, Female, Humans, Menopause, Osteoporosis, Postmenopausal, Estrogen Replacement Therapy, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.